The Managing Director of Miraflash Nigeria Limited (Pharmaceuticals), Pharmacist Moses Oluwalade, has called for a bold and urgent transformation of Nigeria’s pharmaceutical industry. Speaking as chairman at the Award and Dinner Night of the recent 28th Annual Conference of the Association of Industrial Pharmacists of Nigeria (NAIP), he charged industry stakeholders to scale up with purpose, innovate with courage, and transform with urgency.
According to him, the era of half-measures must give way to decisive, strategic reforms that will guarantee health security and elevate Nigeria’s standing in global pharmaceutical markets. “This year’s theme, ‘Scale, Innovation, and Transformation of the Nigerian Pharmaceutical Industry’, is not just a slogan—it is a mandate,” he declared. “It speaks directly to our current challenges and future opportunities.”
Oluwalade emphasised the importance of sustained investments in infrastructure, dependable supply chains, and policy frameworks that favour collaboration over fragmentation. “We must stop working in silos,” he said. “If we want a sustainable pharmaceutical ecosystem in Nigeria, we must build together—manufacturers, regulators, distributors, researchers—no one can succeed alone.”
He argued that innovation in the industry must go beyond technology. For him, it also means embracing new ways of thinking and daring leadership. “It’s about investing in research and development, embracing digital tools, and empowering young professionals to think differently,” he explained. He also urged stakeholders to rethink outdated systems and prioritise digitisation for efficiency and competitiveness.
Oluwalade maintained that the transformation of the local pharmaceutical landscape will remain incomplete unless Nigeria aligns with global standards and improves regulatory performance. However, beyond policies and systems, he noted that transformation must begin with perception, especially the way locally manufactured medicines are regarded. “We must stop seeing locally made medicines as second-best. We are not second-best. We are not an alternative—we are the future,” he declared to loud applause.
Drawing from his own journey in pharmaceutical manufacturing, the Miraflash boss recalled the difficulties he encountered in the early days. “It took resilience, faith in the vision, and a willingness to adapt,” he said. “We built, we failed, we learned, and we rose again.” He encouraged upcoming professionals to hold fast despite the headwinds, noting that perseverance and innovation are what will shape the next phase of the industry.
He also took time to commend the outgoing NAIP leadership, led by Pharm. Ken Onuegbu, for their commitment and legacy. “Your dedication has been commendable. The impact of your leadership will be remembered,” he said. Addressing the newly elected executive members, he urged them to lead with purpose, clarity, and integrity. “Your election is a sign of trust. May your tenure be defined by unity, action, and meaningful progress. Lead with wisdom, listen with empathy, and serve with purpose.”
In his final charge to the gathering, Oluwalade urged the industry not to return to business as usual. “Let us go back to our plants, our pharmacies, and our boardrooms with renewed boldness. Let us commit not just to ambition but to execution,” he concluded.
Scale up, Innovate and Transform with Urgency, Oluwalade Charges Industry Leaders
By Ranmilowo Ojalumo
PIX:- Newly elected NAIP Chairman, Pharm. Bankole Ezebuilo; MD, Miraflash Nigeria Ltd, Pharm. Moses Oluwalade; Dr Lolu Ojo; MD SKG, Dr Okey Akpa; former Chairman of NAIP, Pharm. Ken Onuegbu; and Chairman, Fidson Healthcare PLC, Dr Fidelis Ayebae at the dinner / award night of NAIP’s 28th Annual National Conference, recently.
The Managing Director of Miraflash Nigeria Limited (Pharmaceuticals), Pharmacist Moses Oluwalade, has called for a bold and urgent transformation of Nigeria’s pharmaceutical industry. Speaking as chairman at the Award and Dinner Night of the recent 28th Annual Conference of the Association of Industrial Pharmacists of Nigeria (NAIP), he charged industry stakeholders to scale up with purpose, innovate with courage, and transform with urgency.
According to him, the era of half-measures must give way to decisive, strategic reforms that will guarantee health security and elevate Nigeria’s standing in global pharmaceutical markets. “This year’s theme, ‘Scale, Innovation, and Transformation of the Nigerian Pharmaceutical Industry’, is not just a slogan—it is a mandate,” he declared. “It speaks directly to our current challenges and future opportunities.”
Oluwalade emphasised the importance of sustained investments in infrastructure, dependable supply chains, and policy frameworks that favour collaboration over fragmentation. “We must stop working in silos,” he said. “If we want a sustainable pharmaceutical ecosystem in Nigeria, we must build together—manufacturers, regulators, distributors, researchers—no one can succeed alone.”
He argued that innovation in the industry must go beyond technology. For him, it also means embracing new ways of thinking and daring leadership. “It’s about investing in research and development, embracing digital tools, and empowering young professionals to think differently,” he explained. He also urged stakeholders to rethink outdated systems and prioritise digitisation for efficiency and competitiveness.
Oluwalade maintained that the transformation of the local pharmaceutical landscape will remain incomplete unless Nigeria aligns with global standards and improves regulatory performance. However, beyond policies and systems, he noted that transformation must begin with perception, especially the way locally manufactured medicines are regarded. “We must stop seeing locally made medicines as second-best. We are not second-best. We are not an alternative—we are the future,” he declared to loud applause.
Drawing from his own journey in pharmaceutical manufacturing, the Miraflash boss recalled the difficulties he encountered in the early days. “It took resilience, faith in the vision, and a willingness to adapt,” he said. “We built, we failed, we learned, and we rose again.” He encouraged upcoming professionals to hold fast despite the headwinds, noting that perseverance and innovation are what will shape the next phase of the industry.
He also took time to commend the outgoing NAIP leadership, led by Pharm. Ken Onuegbu, for their commitment and legacy. “Your dedication has been commendable. The impact of your leadership will be remembered,” he said. Addressing the newly elected executive members, he urged them to lead with purpose, clarity, and integrity. “Your election is a sign of trust. May your tenure be defined by unity, action, and meaningful progress. Lead with wisdom, listen with empathy, and serve with purpose.”
In his final charge to the gathering, Oluwalade urged the industry not to return to business as usual. “Let us go back to our plants, our pharmacies, and our boardrooms with renewed boldness. Let us commit not just to ambition but to execution,” he concluded.
